Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (CHC)”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Early research (Phase 1)Study completedNCT02014571
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 37
Testing effectiveness (Phase 2)Study completedNCT01842451
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis CCHCHCV+1 more
Vertex Pharmaceuticals Incorporated 23
Not applicableWithdrawnNCT01062659
What this trial is testing

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm
Post-approval studies (Phase 4)Study completedNCT01258101
What this trial is testing

PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 395
Large-scale testing (Phase 3)WithdrawnNCT01296971
What this trial is testing

The Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT00192647
What this trial is testing

Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 896
Large-scale testing (Phase 3)Study completedNCT00483938
What this trial is testing

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 236
Post-approval studies (Phase 4)Study completedNCT00087607
What this trial is testing

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Not applicableStudy completedNCT02850289
What this trial is testing

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Large-scale testing (Phase 3)Study completedNCT00100659
What this trial is testing

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 114
Post-approval studies (Phase 4)Study completedNCT00087594
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 48
Large-scale testing (Phase 3)Study completedNCT03020082
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 141
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Post-approval studies (Phase 4)Study completedNCT00077649
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 188
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Not applicableUnknownNCT04405011
What this trial is testing

NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC

Who this might be right for
HBV/HCV Co-infection
National Taiwan University Hospital 60
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Load More Results